Figure 8From: Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculationChange in vessel ID in control and diabetic animals during infusion of vasoactive compounds, categorised by branching order and vessel size class. ACh (A &F; 3.0 μg/kg/min), SNP (B &G; 3.0 μg/kg/min), combined (C &H); L-NAME (10 mg/kg iv. bolus) + meclofenamate (2 mg/kg iv. bolus), combined + ACh (D &I) and combined + fasudil (E &J; 10 mg/kg iv.). Fasudil treatment resulted in a marked increase in diabetic second order vessel ID and the 40-100 μm small artery-arterioles compared to controls. Control, n = 6 and diabetic, n = 8. Values expressed as mean ± SEM. †P < 0.05 vs. control.Back to article page